U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: May 7-13, 2023
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: May 7-13, 2023

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 05/08/2023
Location: Virtual
Subject: Reagan-Udall Foundation Evidence Generation Roundtable
FDA Participant/Group: HILARY MARSTON; HANNAH JARMAN-MILLER;
Non FDA Participant/Group: Government, industry, and academia

Event Date: 05/08/2023
Location: Washington, DC
Subject: 2023 Science of Patient Engagement Symposium
FDA Participant/Group: DAYLE CRISTINZIO; JAMES MCKINNEY; KATHRYN CAPANNA;
Non FDA Participant/Group: Government, industry, media, academia, and other registered attendees

Event Date: 05/09/2023
Location: Silver Spring, MD
Subject: Japan's Pharmaceuticals and Medical Devices Agency Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Hayato Kume, Junko Sato, Shinichi Okudaira, Yasuhiro Fujiwara (Pharmaceuticals and Medical Devices Agency);

Event Date: 05/10/2023
Location: Virtual
Subject: Radars System 2023 17th Annual Scientific Meeting: Surveillance of Psychoactive Drugs, Opioids, Psychedelics, and Cannabinoids
FDA Participant/Group: MICHELLE ADAMS;
Non FDA Participant/Group: Government, academia, industry, and other registered attendees

Event Date: 05/11/2023
Location: Virtual
Subject: Generic Drug Science and Research Initiatives Public Workshop
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, academia, media, and other registered attendees

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 05/11/2023
Location: Virtual
Subject: COVID-19 and the Future of Clinical Trials
FDA Participant/Group: N/A
Non FDA Participant/Group: Several Stanford students and staff

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 05/08/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Julie Gerberding (The Foundation for the National Institutes of Health (FNIH));

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 05/08/2023
Location: Virtual
Subject: International Coalition of Medicines Regulatory Authorities Workshop: COVID-19 Vaccines Composition Updates; Vaccine Strain Selection Update - U.S. Perspective
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of International Coalition of Medicines Regulatory Authorities Workshop: COVID-19 Vaccines Composition Updates

Event Date: 05/12/2023
Location: Virtual
Subject: Cellular, Tissue, and Gene Therapies Advisory Committee Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of Cellular, Tissue, and Gene Therapies Advisory Committee Meeting

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 05/09/2023
Location: Silver Spring, MD
Subject: General Medical Devices Discussion
FDA Participant/Group: SEMA HASHEMI; KENNETH CAVANAUGH; MELISSA TORRES;
Non FDA Participant/Group: Dr. Yasu Fujiwara (Pharmaceuticals and Medical Devices Agency );

Event Date: 05/11/2023
Location: Silver Spring, MD
Subject: Cybersecurity of Medical Devices
FDA Participant/Group: WILLIAM MAISEL; LINDA RICCI; MATTHEW HAZELETT; ANGELA KRUEGER; KEISHA THOMAS; AFTIN ROSS; SUZANNE SCHWARTZ; KATELYN BITTLEMAN; JESSICA WILKERSON;
Non FDA Participant/Group: Scott Trevino, Tim McGeath (TriMedx); Rick Staab (InterMed Group); Shelia O’Donnell (Crothall); Heidi Drafall (Agiliti); Andrew Coats (Hall Render); Binseng Wang (Sodexo);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

Event Date: 05/09/2023
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from Keep Antibiotics Working (KAW)

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top